l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide has been researched along with triiodothyronine in 2 studies
Studies (l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide) | Trials (l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide) | Recent Studies (post-2010) (l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide) | Studies (triiodothyronine) | Trials (triiodothyronine) | Recent Studies (post-2010) (triiodothyronine) |
---|---|---|---|---|---|
138 | 7 | 2 | 26,247 | 861 | 3,473 |
Protein | Taxonomy | l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide (IC50) | triiodothyronine (IC50) |
---|---|---|---|
Thyroid hormone receptor alpha | Homo sapiens (human) | 0.0006 | |
Thyroid hormone receptor beta | Homo sapiens (human) | 0.0006 | |
Proliferating cell nuclear antigen | Homo sapiens (human) | 3.6 | |
Thyroid hormone receptor beta | Rattus norvegicus (Norway rat) | 0.0031 | |
Adenosine receptor A1 | Homo sapiens (human) | 0.4109 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Eckland, DJ; Guiloff, RJ; Lightman, SL; Modarres-Sadeghi, H | 1 |
Eckland, DJ; Lightman, SL | 1 |
1 trial(s) available for l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide and triiodothyronine
Article | Year |
---|---|
The TSH, T4, T3 and prolactin responses to consecutive infusions of a potent and stabilized thyrotrophin releasing hormone analogue, RX77368, in man.
Topics: Adult; Central Nervous System; Humans; Male; Prolactin; Pyrrolidonecarboxylic Acid; Receptors, Neurotransmitter; Receptors, Thyrotropin-Releasing Hormone; Thyroid Hormones; Thyrotropin; Thyrotropin-Releasing Hormone; Thyroxine; Triiodothyronine | 1988 |
1 other study(ies) available for l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide and triiodothyronine
Article | Year |
---|---|
The effects of repeated administration of a long acting TRH analogue (RX77368), on TSH, T4, T3 and prolactin in patients with motor neuron disease.
Topics: Aged; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Motor Neurons; Neuromuscular Diseases; Prolactin; Pyrrolidonecarboxylic Acid; Thyrotropin; Thyrotropin-Releasing Hormone; Thyroxine; Triiodothyronine | 1990 |